The determinants of activated partial thromboplastin time, relation of activated partial thromboplastin time to clinical outcomes, and optimal dosing regimens for heparin treated patients with acute coronary syndromes: a review of GUSTO-IIb.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples